Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism Respiratory syncytial virus F protein inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Respiratory Syncytial Virus Infections | Preclinical | NL | 10 Jul 2015 | |
Respiratory Syncytial Virus Infections | Preclinical | US | 10 Jul 2015 |